112 related articles for article (PubMed ID: 2782920)
1. [Pharmacokinetics of cisplatin and vindesine in a patient with chronic renal failure undergoing hemodialysis].
Ayabe H; Uchikawa T; Kimino K; Tagawa Y; Kawahara K; Tomita M
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3283-5. PubMed ID: 2782920
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of cisplatin and methotrexate in a patient suffering from advanced ureteral tumor accompanied by chronic renal failure, undergoing combined hemodialysis and systemic M-VAC chemotherapy].
Tokunaga J; Kikukawa H; Nishi K; Kitani K; Fujii J; Honda J; Wada Y; Ueda S; Nakano M
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2079-85. PubMed ID: 11103239
[TBL] [Abstract][Full Text] [Related]
3. [Etoposide and cisplatin combination chemotherapy in a patient with small cell lung carcinoma under artificial hemodialysis].
Ono S; Miyazaki T; Nishikawa K; Watanabe K; Hisanaga S
Gan To Kagaku Ryoho; 1992 Jan; 19(1):115-8. PubMed ID: 1309629
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of cis-dichlorodiammine platinum (II) in patients undergoing hemodialysis].
Miyakawa M; Sugimoto K; Ohe Y; Masuoka H; Miyahara T
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2491-5. PubMed ID: 3619461
[TBL] [Abstract][Full Text] [Related]
5. [Combined 5-FU and CDDP in a gastric cancer patient undergoing hemodialysis--pharmacokinetics of 5-FU and CDDP].
Cho H; Imada T; Masudo K; Doi C; Inaba M; Tokunaga M; Takanashi Y
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2135-8. PubMed ID: 11103248
[TBL] [Abstract][Full Text] [Related]
6. [Study on changes in plasma platinum concentrations after administration of CDDP to maintenance hemodialysis patients].
Suwata J; Hiraga S; Hida M; Takamiya T; Iida T; Sato T
Gan To Kagaku Ryoho; 1988 Feb; 15(2):243-8. PubMed ID: 3341786
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of cisplatin in long-term hemodialysis treatment].
Sturn W; Sanwald R; Ehninger G
Dtsch Med Wochenschr; 1989 Mar; 114(9):337-9. PubMed ID: 2920679
[TBL] [Abstract][Full Text] [Related]
8. [M-VAC therapy in a patient with ureteral carcinoma accompanied by chronic renal failure].
Yokogi H; Yamasaki Y; Ishibe T
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2405-7. PubMed ID: 8259861
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy for an esophageal cancer patient undergoing continuous ambulatory peritoneal dialysis for chronic renal failure and measurement of plasma concentration of the drug].
Okuyama M; Motoyama S; Maruyama K; Ohta H; Tsuchiya N; Oyake J; Ogawa J
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1029-32. PubMed ID: 16044967
[TBL] [Abstract][Full Text] [Related]
10. [48-hour continuous infusion of vindesine (followed by cisplatin) in advanced lung cancer. Chronopharmacokinetic data and clinical efficacy].
Focan C; Doalto L; Mazy V; Levi F; Bruguerolle B; Cano JP; Rahmani R; Hecquet B
Bull Cancer; 1989; 76(8):909-12. PubMed ID: 2620124
[No Abstract] [Full Text] [Related]
11. [Chemotherapy with nedaplatin for an oral floor cancer patient undergoing chronic hemodialysis].
Iwasaki A; Tanizaki A; Ohbayashi Y; Miyake M; Nagahata S; Takahashi N
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2231-4. PubMed ID: 11142167
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of vindesine infusion.
Rahmani R; Kleisbauer JP; Cano JP; Martin M; Barbet J
Cancer Treat Rep; 1985; 69(7-8):839-44. PubMed ID: 2410121
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
[TBL] [Abstract][Full Text] [Related]
14. [Plasma concentration of 4'-epi-adriamycin in hemodialysis patients].
Tomoe H; Nishino S; Koyama I; Uda M; Toma H
Gan To Kagaku Ryoho; 1992 Apr; 19(4):549-51. PubMed ID: 1558406
[No Abstract] [Full Text] [Related]
15. [Nedaplatin and etoposide combination chemotherapy in a patient with small cell carcinoma undergoing hemodialysis].
Nishioka Y; Kitada O; Meguro T; Aragane K; Tanimukai T; Nakamura H; Nakahama H; Matsuyama T; Sugita M; Yano T; Takenaka Y; Takamitsu Y
Gan To Kagaku Ryoho; 1999 Mar; 26(4):527-30. PubMed ID: 10097751
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. [Definitive end-stage chronic kidney failure after cisplatin treatment].
Brillet G; Deray G; Lucsko M; Faucher C; Aubert P; Rottembourg J; Jacobs C
Nephrologie; 1993; 14(5):227-9. PubMed ID: 8159252
[TBL] [Abstract][Full Text] [Related]
18. Optimization of cisplatin doses in a testicular cancer patient with acute renal failure.
Pouliquen AL; Bousquet G; Le Maignan C; Bauer C; Lejri N; Misset JL; Lokiec F
J Oncol Pharm Pract; 2011 Sep; 17(3):265-9. PubMed ID: 19933251
[TBL] [Abstract][Full Text] [Related]
19. [Combination chemotherapy with carboplatin and etoposide against lung adenocarcinoma in a patient undergoing hemodialysis: a case report].
Yanagawa H; Takishita Y; Bando H; Shinohara T; Tanaka H; Sumitani H
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2409-11. PubMed ID: 8259862
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
Hohnloser JH; Schierl R; Hasford B; Emmerich B
Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
